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Abstract Influenza virus infections have a significant impact on global human health. Individuals
with suppressed immunity, or suffering from chronic inflammatory conditions such as COPD, are
particularly susceptible to influenza. Here we show that suppressor of cytokine signaling (SOCS)
five has a pivotal role in restricting influenza A virus in the airway epithelium, through the regulation
of epidermal growth factor receptor (EGFR). Socs5-deficient mice exhibit heightened disease
severity, with increased viral titres and weight loss. Socs5 levels were differentially regulated in
response to distinct influenza viruses (H1N1, H3N2, H5N1 and H11N9) and were reduced in
primary epithelial cells from COPD patients, again correlating with increased susceptibility to
influenza. Importantly, restoration of SOCS5 levels restricted influenza virus infection, suggesting




Influenza A virus is a single stranded RNA virus that infects the upper respiratory tract and has a
major impact on global health. In most instances the effects are largely socioeconomic, with infected
individuals requiring bed-rest and recovering at home. However, for the very young, pregnant
women, the elderly and the infirm, severe influenza can result in hospitalisation and even death, with
seasonal strains accounting for 500,000 deaths annually (Hsu et al., 2012b; Vanders et al., 2015).
Those that succumb to the disease can die as a result of an unrestrained inflammatory response
(often referred to as a ‘cytokine storm’), which together with cell death irretrievably damages the air-
ways releasing fluid into the alveolar spaces (Short et al., 2014). Individuals who suffer from pre-
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existing respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD) are
at increased risk of influenza and suffer more severe clinical symptoms (Glezen et al., 2000;
Griffin et al., 2002).
The global community is constantly on the alert for novel avian influenza strains (Hansbro et al.,
2010) that might acquire the ability to spill over from birds to humans and against which we have no
pre-existing antigenic immunity, thus raising the very real threat of a global pandemic (as occurred
during the 1918 Spanish Flu). For example, the virulent H5N1 virus, when transmitted from birds to
humans has a 50% mortality rate (Fauci, 2006) and since 2013, bird-to-human transmission of the
H7N9 virus has resulted in over 600 confirmed cases with a mortality rate of approximately 38%, trig-
gering an emergency response in China (Hsu et al., 2011; Xu et al., 2013). If such a virus evolved
the capacity to transmit efficiently from human-to-human, the effects would be devastating
(Fauci, 2006).
It is not clear why only some individuals respond to infection with exacerbated inflammatory
responses. Similarly, the aetiology surrounding sufferers of chronic respiratory disease and their sus-
ceptibility to influenza remains poorly understood (Hsu et al., 2012b). We are however, beginning
to understand the innate immune sensors that initiate the immune defence to viral pathogens and
the ability of the influenza virus to evade and indeed hijack the host defence to facilitate viral entry
and replication (Hsu et al., 2015).
Encapsulated within the influenza viral envelope are eight RNA segments that encode 11 pro-
teins. Viral entry occurs via attachment of the surface glycoprotein hemagglutinin (HA) to sialic acid
residues on the surface of host respiratory epithelial cells. Endocytosis of the viral particles is accom-
panied by clustering of adjacent receptor tyrosine kinases into lipid rafts. The EGF receptor (EGFR)
is one such example, and virus-dependent clustering of the receptor results in activation of EGFR
kinase activity and downstream phosphoinositide-3-kinase (PI3K) signaling, which not only facilitates
viral entry, but has been shown to suppress interferon regulatory factor (IRF)-induced interferon
(IFN) production (Eierhoff et al., 2010; Hsu et al., 2015; Ueki et al., 2013).
Viral RNA generated during replication is detected by host pattern-recognition receptors, specifi-
cally by the retinoic-acid induced gene I (RIG-I)-like RNA sensors RIG-I and Melanoma
eLife digest Influenza, commonly referred to as the flu, is a highly contagious disease caused by
a virus. When an infected person coughs or sneezes, droplets containing the virus are released into
the air. Other individuals nearby may breathe in the virus, which then enters the cells lining the lungs
and multiplies.
Some people are more susceptible to the influenza virus than others. In particular, individuals
with chronic obstructive pulmonary disease (COPD) often suffer much worse flu symptoms and are
more likely to be admitted to hospital. COPD results from smoke exposure, including cigarette
smoke and, in developing countries, the smoke from cooking fires, but it is not clear why individuals
with COPD are more susceptible to the influenza virus.
The influenza virus gains entry to lung cells by manipulating receptors on the cell surface. A
protein called SOCS5 is present inside these cells and has been suggested as a potential regulator
of these receptors. Here, Kedzierski et al. reveal that SOCS5 plays a critical role in protecting lung
cells in mice and humans from the virus.
The experiments show that mice lacking the gene that encodes SOCS5 were more susceptible to
infection by the influenza virus, had more severe symptoms of disease and increased amounts of
virus in their lungs. Further experiments in lung cells collected from human volunteers show that
SOCS5 levels increased in both healthy smokers and non-smokers in response to influenza infection.
Conversely, SOCS5 levels in lung cells of smokers with COPD remained low after infection. This
suggests that SOCS5 might be an important factor in the susceptibility of these patients to
influenza.
The next is step is to understand exactly how SOCS5 works, which may make it possible to
develop new treatments that boost SOCS5 activity in influenza patients.
DOI: 10.7554/eLife.20444.002
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Differentiation-Associated gene 5 (MDA-5) in the cytoplasm and by Toll-like receptor (TLR)s 3, 7 and
8 in the late endosomes (Guillot et al., 2005; Hsu et al., 2012b). Activation of these pathways indu-
ces production of type I (IFNa/b) and type III (IFNl) interferons and subsequently, the transcription
of interferon response genes, which are critical for generating an anti-viral state (Crotta et al., 2013;
Seth et al., 2005). The constitutive production of type I IFNs also contributes to anti-viral immunity
(Hsu et al., 2012a). Ultimately, TLR and RIG-I signaling pathways converge to induce pro-inflamma-
tory chemokines and cytokines, and recruit a wave of infiltrating immune cells.
Several influenza viral proteins thwart the host response, most notably the multi-functional non-
structural 1 (NS1) protein, which interacts with numerous host proteins to inhibit mRNA processing
and export, prevent IFN production and alter the intracellular environment (Marc, 2014;
Samji, 2009). For instance, NS1 interacts with the p85 subunit of PI3K to stabilise the kinase com-
plex and promote AKT phosphorylation, enhancing viral entry and inhibiting protective apoptosis
(Ehrhardt and Ludwig, 2009).
The suppressor of cytokine signaling proteins (CIS, SOCS1-7) are an important family of small
intracellular proteins which act to limit the duration of signaling responses. They primarily act as
adaptor proteins to recruit an E3 ubiquitin ligase complex and facilitate the ubiquitination of sub-
strates bound to the SOCS-SH2 domain or N-terminal region, marking them for proteasomal degra-
dation (Linossi and Nicholson, 2012). While the physiological role and mechanism of action of
SOCS1 and particularly SOCS3, are well understood, much less is known about the other family
members (SOCS4-7), which in addition to the central phosphotyrosine-binding SH2 domain and
C-terminal SOCS box, contain an extended N-terminal region (Feng et al., 2012). Although SOCS5
has been suggested to regulate EGF (Kario et al., 2005; Nicholson et al., 2005) and IL-4 signaling
(Seki et al., 2002), there is a paucity of data to support a role for SOCS5 as a physiological regulator
of these pathways in mammalian cells.
Here we show for the first time that SOCS5 has a unique role in restraining the early phase of
influenza A infection in airway epithelial cells. We highlight a novel role for SOCS5 in the regulation
of PI3K signaling and demonstrate that SOCS5 primarily protects against viral infection by inhibiting
EGFR activity. Given the reduced SOCS5 levels in epithelial cells from COPD patients, this provides
a hitherto unknown link that may explain the increased susceptibility of COPD patients to influenza
virus infection.
Results
Socs5 /  mice show increased susceptibility to influenza A virus
infection
To examine the role of SOCS5 during an infectious challenge, we infected wild-type and Socs5 / 
BALB/c mice with the influenza virus strain A/Puerto Rico/8/32 (H1N1; PR8). Mice lacking Socs5 lost
significantly more body weight following PR8 infection compared to wild-type BALB/c mice
(Figure 1A). This was evident at day 3 of infection and correlated with a significantly increased viral
load in the lung (Figure 1B). Interestingly, elevated levels of virus were present in Socs5 /  lungs
from day 1, prior to infiltration of immune cells and suggesting that Socs5 /  mice had a reduced
innate ability to restrain early viral replication. This difference was comparable to the increased levels
of virus observed in SirpA-deficient mice which lack natural killer (NK) cells, T and B cells and innate
lymphoid cells (ILCs) (Legrand et al., 2011), but not as great as that observed in Socs4 /  mice chal-
lenged with PR8 (Figure 1—figure supplement 1).
We had previously shown that SOCS4 restrains viral infection via the hematopoietic compartment,
most likely through regulating CD8+ T cell function (Kedzierski et al., 2014). We therefore investi-
gated the contribution of the hematopoietic compartment to the increased susceptibility to influenza
virus observed in the Socs5 /  mice. Chimeric mice were generated by bone marrow transplantation
into irradiated, congenic-recipient mice, which were then challenged with PR8 virus. Transplantation
of wild-type bone marrow into Socs5 /  hosts resulted in greater weight loss and elevated viral
titres, when compared to transplantation of Socs5 /  bone marrow into irradiated wild-type hosts
(Figure 1C,D). This strongly suggested that the Socs5 /  defect occurred predominately in non-
hematopoietic tissues.
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Figure 1. Socs5 /  mice show increased susceptibility to influenza A virus infection. (A) Mice were infected i.n.
with 25 pfu influenza virus H1N1 PR8 and weight loss monitored for 7 days. Mice that lost more than 20% of their
initial body weight were euthanized. Mean ± S.E.M.; n = 9. (B) Comparison of viral titres in lung homogenates on
days 1, 2, 3 and 5 post-PR8 infection. (C,D) Lethally irradiated Socs5+/+ Thy1.1 mice were reconstituted with
Figure 1 continued on next page
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Socs5 is expressed in airway epithelial cells and is upregulated in
response to influenza virus infection
Socs5 mRNA was expressed in uninfected mouse lungs and was significantly upregulated at day two
post-infection; by comparison, Socs4 was expressed at very low levels even during infection
(Figure 1E). These data were confirmed at the protein level by immunoprecipitation and immuno-
blotting with anti-SOCS5 antibodies, which detected a prominent band migrating at ~67 kDa in
wild-type, but not Socs5 /  lungs (Figure 1F). Immunohistochemistry demonstrated specific staining
in wild-type lungs, which was increased during infection and was predominately localized to the air-
way epithelial cells lining the bronchioles (Figure 1G).
Increased influenza severity in the Socs5 /  mice is associated with
increased inflammation and neutrophil infiltration
Pro-inflammatory cytokines and chemokines were elevated in the bronchoalveolar lavage (BAL) from
Socs5 /  mice, day two post-infection. In particular, the cytokines interleukin (IL)-6 and G-CSF, and
the chemokines KC, MCP-1 and MIP-1b were elevated compared to controls (Figure 2A). In con-
trast, type I and type III IFNs were not increased in Socs5 /  lung homogenates, whilst the levels of
IFNa, b and l appeared to be modestly decreased at day one post-infection (Figure 2B).
There was also an increase in the total number of cells infiltrating into the airways (Figure 2C).
This was accounted for by an increase in neutrophils and is consistent with the elevated cytokine/
chemokine levels, in particular the known roles of IL 6 and G-CSF in neutrophil activation and sur-
vival, and of KC and MCP-1 in neutrophil recruitment (Soehnlein and Lindbom, 2010). There were
no differences observed in infiltrating monocytic cells, T or B cells (Figure 2C and Figure 2—figure
supplement 1). At day two post-infection, these changes were apparent at a global level in Socs5 /
  lungs, with quantitative proteomic analysis showing increased expression of neutrophil proteins
and neutrophil chemotactic proteins, in addition to detection of viral NS1, HA and NP proteins
(Figure 2D,E and Table 1). A total of 1907 unique mouse proteins were identified, with 23 differen-
tially regulated in Socs5 /  lungs. Interestingly, a number of histones were also upregulated in
Socs5 /  lungs. Together with increased Hmgb2 and various neutrophil effector proteins, this signa-
ture is strongly reminiscent of neutrophil extracellular traps (NETs) (Khandpur et al., 2013;
Urban et al., 2009), a mechanism whereby dying neutrophils extrude DNA ‘nets’ coated with
nuclear and granular proteins, to trap and kill the invading microorganisms (Rohrbach et al., 2012)
(Figure 2D,E and Table 1). This was further supported by the increased amount of extracellular
DNA found in Socs5 /  lungs (Figure 2—figure supplement 2) and by the detection of citrullinated
modifications on the differentially expressed proteins (lactotransferrin, neutrophil elastase) (Table 1)
(Wang et al., 2009).
Collectively, these data suggest that the heightened susceptibility to influenza observed in
Socs5 /  mice results from a defect in the lung epithelium, with the increased viral titre in the
Socs5 /  lungs initiating an inflammatory cascade that is driven primarily by neutrophil infiltration
(Figure 2F).
Figure 1 continued
Socs5 /  Thy1.2 bone marrow (n = 8) or the reciprocal transplantation was performed (n = 9), following which mice
were infected with H1N1 PR8 virus. Weight loss (C) was monitored for 7 days, at which time lungs were harvested
for (D) viral titre estimation. *p<0.05, **<0.005, ***<0.001; mean ± S.E.M. (E) Lungs from wild-type and Socs5 / 
mice were harvested at day (D) two post-infection and analyzed for Socs5 and Socs4 mRNA expression by Q-PCR.
The results were normalized to 18SrRNA levels. Mean ± S.E.M.; N.D.=Not detected; n = 3 uninfected (U/I) wild-
type mice, n = 6 infected wild-type mice, n = 6 infected Socs5 /  mice. (F) Lungs were lysed at day 1 and 2 post-
infection and SOCS5 protein levels analyzed by immunoprecipitation and immunoblotting. (G) Lung
immunohistochemistry showing SOCS5 expression (brown staining) in wild-type (+/+) airway epithelium at day
three post-infection. The following figure supplement is available for Figure 1.
DOI: 10.7554/eLife.20444.003
The following figure supplement is available for figure 1:
Figure supplement 1. Comparison of viral titres.
DOI: 10.7554/eLife.20444.004
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Figure 2. Socs5 /  mice have an exaggerated inflammatory response in the lungs to influenza A virus infection. (A) Cytokine and chemokine levels
were analyzed by Bioplex in bronchoalveolar lavage (BAL) fluid recovered from lungs at day two post-infection with 25 pfu influenza virus H1N1 PR8.
*p<0.05, **<0.005; Mean ± S.E.M.; n = 7 for Socs5+/+, n = 8 for Socs5 / . (B) Expression of type I and type III interferon (IFN) in the lungs at day 1 and
day two post-infection was measured by ELISA. *p<0.05; Mean ± S.D.; day 1: n = 5 for Socs5+/+, n = 6 for Socs5 / ; day 2: n = 8. (C) Flow cytometric
analysis was performed on cells in BAL. Cells were gated on CD11b+ and subdivided into CD11c+ APC (dendritic cells and alveolar macrophages),
Ly6G+ neutrophils and Ly6C+ inflammatory monocytes. Gated lymphocytes were subdivided into B220+ B cells and CD4+ and CD8+ T cells. *p<0.05,
**<0.005, ns = not significant; Individual and mean values; n = 7 for Socs5+/+, n = 8 for Socs5 / . (D,E) Mice were infected and lungs lysed at day two
post-infection for label-free quantification of global protein expression. Volcano plot (D) shows the Log2 protein ratios following the quantitative
pipeline analysis (Socs5+/+ vs Socs5 / ). The red and yellow lines represent a 2-fold change in protein expression (log2 ratio of 1), while blue and green
lines represent a 4-fold change (log2 ratio of 2); dots are coloured accordingly and represent individual proteins. Proteins with a -log10 p-value of 1.3 or
greater (corresponding to a p-value of 0.05) were deemed differentially abundant. (E) Heat map displaying Log2-transformed summed peptide
intensities (non-imputed) for proteins with significantly differential expression in (D). Data from individual biological replicates are shown (n = 4). Green
to red indicates increasing expression levels. (F) Schematic showing the relationship between increasing viral load and inflammation.
DOI: 10.7554/eLife.20444.005
The following figure supplements are available for figure 2:
Figure supplement 1. Gating strategy for flow cytometric analysis.
DOI: 10.7554/eLife.20444.006
Figure supplement 2. Increased NETosis in Socs5 /  lungs during influenza virus infection.
DOI: 10.7554/eLife.20444.007
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Socs5 /  primary mouse airway epithelial cells (mAEC) have increased
intrinsic susceptibility to influenza virus infection
To determine whether the enhanced susceptibility to infection was intrinsic to the pulmonary epithe-
lial cells, lungs were harvested from wild-type and Socs5 /  mice and purified mAECs cultured for 7
days prior to infection with influenza virus PR8 strain (Figure 3A). At low levels of virus (MOI 1.25
and 2.5), there was a higher percentage of infected Socs5 /  mAECs in comparison to wild-type
cells (Figure 3B), suggesting that Socs5 /  mAECs may be more permissive for viral infection. How-
ever, this difference was lost once the initial inoculum was increased (MOI 5 and 10; >74% infected
cells). When a low MOI was used in the presence of trypsin (to ensure multiple rounds of replication

















Q3UP42 Protein S100-A9 S100a9 2.90 2.94E-02 2 2 NET-associated protein
P62806 Histone H4 Hist1h4a 2.53 7.82E-03 4 3 NET-associated protein
Q3UP87 Neutrophil elastase* Elane 2.43 2.66E-02 2 1 NET-associated protein
Q53  15 Protein S100-A8 S100a8 2.30 3.38E-04 3 3 NET-associated protein
Q91XL1 Leucine-rich alpha-2-
glycoprotein
Lrg1 2.07 1.14E-02 3 0 Neutrophil differentiation
Q61646 Haptoglobin Hp 2.05 1.03E-04 13 9 Produced by neutrophils
Q542I8 Integrin beta 2 (Mac-1) Itgb2 2.00 7.85E-03 6 1 Induces Net formation
Q7TMS4 Myeloperoxidase Mpo 1.97 4.18E-06 14 2 NET-associated protein
P51437 Cathelin-related
antimicrobial peptide
Camp 1.90 1.10E-02 3 1 Highly expressed in neutrophils
Q4FJR3 Lactotransferrin* Ltf 1.87 4.43E-11 26 13 NET-associated protein
O08692 Neutrophilic granule
protein
Ngp 1.76 1.10E-02 6 4 In neutrophil granules
Q99K94 Signal transducer and
activator of transcription 1
Stat1 1.68 5.80E-05 11 4 Low in neutrophils – could be
upregulated in response to IFN or
EGFR?
P20152 Vimentin Vim 1.67 1.99E-05 14 3 NET-associated protein
Q3UV87 Chitinase-3-like protein 3
(YM1)
Chi3l3 1.65 1.53E-06 9 6 Produced by neutrophils
A0JLV3 Histone H2B Hist1h2bj 1.32 9.49E-04 3 3 NET-associated protein
G3  9V0 Proteasome activator
complex subunit 2
Psme2 1.63 1.36E-02 7 5
Q5RKN9 F-actin-capping protein
subunit alpha-1




Hpgd 1.63 1.87E-03 3 1 Not in neutrophils?
Q3UAZ7 High mobility group
protein B2
Hmgb2 1.62 3.03E-04 4 2 Hmgb1: component of neutrophil
NET filaments/induces NET formation
Q8BH61 Erythrocyte membrane
protein band 4.2
Epb4.2 1.51 7.57E-03 5 1 Neutrophil protein
F8WIX8 Histone H2A Hist1h2al 1.44 1.73E-02 2 2 NET-associated protein
Q6PEN2 Protein Gbp6 Gbp6 1.41 1.36E-03 3 1 Not in neutrophils?
Q9Z2I8-2 Succinyl-CoA ligase
subunit beta
Suclg2  1.36 4.19E-03 1 3
* indicates the detection of citrullinated peptides.
Note: Given that trypsin cleaves at arginine and lysine residues and citrullination is a modification of arginine, it is likely that citrullination impacts on the
efficiency of the tryptic digest. Hence, we may be underestimating the number of citrillinated proteins present.
DOI: 10.7554/eLife.20444.008
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and release from the cells), Socs5 /  mAECs showed elevated viral titres 24 and 48 h post-infection,
confirming the reduced capacity of Socs5 /  mAECs to restrain viral replication (Figure 3C). Consis-
tent with our in vivo results, there was increased cytokine and chemokine production, with elevated
IL-6, G-CSF, MCP-1, MIP-1a and RANTES at 24 h post-infection (MOI 5). Of these, G-CSF and MCP-
1 showed the greatest differential expression (Figure 3D).
These results provide evidence for an intrinsic epithelial cell defect, which manifests in increased
levels of virus and is likely to be, at least in part, responsible for the phenotype observed in Socs5 / 
mice (Figure 1).
SOCS5 regulates EGF-PI3K signaling
To investigate which pathways might be perturbed in the absence of Socs5, whole lung lysates were
analyzed by immunoblotting for the activation of various anti- and pro-viral signaling intermediates.
Given that exogenous expression of SOCS5 has been shown to downregulate EGFR levels
(Nicholson et al., 2005), we included analysis of EGFR expression. Lungs from uninfected Socs5 / 
mice showed increased expression of the p110a catalytic subunit of PI3K, and apart from slightly
reduced levels of phosphorylated (p)AKT and PI3K p85, other signaling proteins remaining
unchanged (Figure 4A,B). At day one post-infection, the expression of EGFR and PI3K p85 and
p110a subunits were increased in Socs5 /  lungs. Further, there was also an increase in pAKT and
pSTAT3. In contrast, the levels of pMAPK and total RIG-I were comparable in wild-type and Socs5 / 
lungs (Figure 4A,B).
To determine whether SOCS5 existed in the same protein complexes as PI3K, Flag-tagged
SOCS5 was expressed in 293T cells, immunoprecipitated and mass spectrometry used to interrogate
protein complex composition (Figure 5A and Table 2). SOCS box components (Elongins B and C,
Rbx2 and Cullin5) were specifically enriched in SOCS5 immunoprecipitates, but not from cells trans-
fected with vector alone. Similarly, the PI3K subunits p85 (PIK3R1), p85b (PIK3R2) and p110b
(PIK3CB) were enriched in SOCS5 complexes (Figure 5A and Table 2). We confirmed these results
by immunoblotting SOCS5 complexes. The SOCS5:PI3K (p85; p110a/b) complex was enriched in
cells pre-treated with vanadyl hydroperoxide (pervanadate) (to block phosphatase activity), indicat-
ing that SOCS5 interaction with the PI3K complex was dependent on phosphorylation of one of the
components (Figure 5B). Further, mutation of the SOCS5-SH2 domain (R406K) or deletion of the
N-terminal 349 residues (DNT) reduced SOCS5 interaction with the PI3K complex, whereas mutation
of the SOCS box (L484P, C488F) had no effect on binding. Importantly, we utilised the lung epithe-
lial A549 cell line to confirm, by co-immunoprecipitation, that endogenous SOCS5 and PI3K co-
existed in a protein complex (Figure 5D).
This suggests that the EGFR and PI3K signaling complexes might be direct targets for SOCS5
regulation and that recruitment of the PI3K complex is mediated, at least in part, via a canonical
SOCS5-SH2:phosphotyrosine interaction. Notably, the difference in PI3K p110a expression in lungs
was detected prior to infection, suggesting that exaggerated activation of this pathway might under-
lie the increased viral susceptibility in the Socs5 /  mice. In contrast, the changes in EGFR levels and
AKT/STAT3 phosphorylation appeared to be influenza virus-induced effects, albeit dependent on
SOCS5.
SOCS5 expression in primary human airway epithelial cells correlates
with increased susceptibility to influenza virus infection
It was important to ascertain the role of SOCS5 in human disease and understand the consequences
of changes in SOCS5 expression. This was particularly relevant given the previous finding that PI3K
activity was elevated in AECs from COPD patients (Hsu et al., 2015).
Primary human airway epithelial cells (hAECs) were obtained by endobronchial brushing from
healthy individuals, smokers with no evidence of lung disease (smokers) and ex-smokers suffering
from COPD, and examined by Q-PCR for Socs5 expression following infection with various human
(H3N2, H1N1; MOI 5) and avian (H11N9; MOI 5) influenza strains. In cells from healthy individuals,
SOCS5 was elevated in response to influenza virus infection with all three strains. However, in cells
obtained from individuals with COPD, Socs5 barely increased above basal levels and was signifi-
cantly lower than in hAECs from healthy individuals (non-smokers or smokers) (Figure 6A). In
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contrast to infection with H3N2, H1N1 and H11N9, infection with the highly pathogenic avian virus
H5N1 dramatically suppressed Socs5 expression relative to the media control (Figure 6B).
We next sought to test the hypothesis that SOCS5 might be regulating viral infection via negative
regulation of EGFR and/or PI3K signaling. As an initial step, we examined levels of SOCS5 protein,
phosphorylated EGFR, PI3K p110a/p85 and phosphorylated AKT in hAECs from healthy individuals,
and COPD patients (Figure 6C–F, and Figure 6—figure supplement 1). SOCS5 protein was
induced in healthy cells 24 h post-H1N1 infection (Figure 6C,D) and was consistently reduced in cells
from COPD patients, both at a basal level and with limited induction in response to virus
(Figure 6C–F and Figure 6—figure supplement 1A,B). SOCS5 expression inversely correlated with
p110a levels and virus-induced EGFR phosphorylation, AKT phosphorylation and viral protein, which
was elevated in COPD hAECs as indicated by detection of intracellular viral HA protein (Figure 6—
figure supplement 1A,B).
Figure 3. Socs5 /  airway epithelial cells have increased intrinsic susceptibility to influenza virus infection. (A)
Primary mouse airway epithelial cells (mAEC) from wild-type and Socs5 /  mice were purified and cultured in vitro
for 7 days prior to infection with influenza virus H1N1 PR8. (B) 8 h post-infection cell monolayers were fixed and
stained by immunofluorescence for detection of viral nuclear protein. Results are shown as the mean % of infected
cells from four technical replicates and are representative of 2 experiments. (C) mAEC were infected with PR8
(MOI 1) and then incubated in the presence of trypsin for 2, 8, 24 and 48 h. Culture supernatants were analyzed for
infectious virus by plaque assay. Results are shown as the fold increase over the level of virus present at 2 h post-
infection. Mean ± S.E.M. are shown for three technical replicates and are representative of 2 experiments. (D)
mAECs were infected (MOI 5) and cytokine levels in culture supernatants measured by Bioplex at 24 h post-
infection. Individual and mean values are shown for technical replicates derived from purified cells pooled from
five mice and are representative of 2 experiments. *p<0.05.
DOI: 10.7554/eLife.20444.009
Kedzierski et al. eLife 2017;6:e20444. DOI: 10.7554/eLife.20444 9 of 27











































































































































Figure 4. EGF-PI3K signaling is enhanced in Socs5 /  lungs. (A) Whole lungs were harvested from uninfected wild-type (+/+) and Socs5 /  ( / ) mice
or from mice at 24 h post-infection with 50 pfu influenza virus H1N1 PR8. Following tissue lysis 100 mg protein from each mouse was analyzed by
immunoblotting with antibodies to the indicated proteins. p: phosphorylated. Note that as they are analyzed on separate gels, uninfected samples
Figure 4 continued on next page
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To determine whether SOCS5 expression -was functionally linked to pathogenicity, hAECs were
cultured from healthy individuals or COPD patients and SOCS5 either reduced using siRNA (SOCS5-
si) or increased by transient transfection (SOCS5) (Figure 6C–F and Figure 6—figure supplements
1 and 2). Depletion of SOCS5 resulted in enhanced levels of the PI3K p110a catalytic subunit in
both healthy and COPD hAECs and this occurred independently of virus. Depletion of SOCS5 also
resulted in increased viral-induction of EGFR phosphorylation, and the changes in EGFR and PI3K
again correlated with increased viral HA levels 2 h post-infection. Phosphorylation of AKT was also
enhanced in some experiments (Figure 6—figure supplements 1C, 2 and 3). Conversely, forced
SOCS5 expression resulted in reduced p110a and EGFR levels and reduced EGFR phosphorylation.
Figure 4 continued
cannot be compared to infected samples. (B) Densitometric values derived from (A) were analyzed as follows: Data from uninfected mice were




































































































































































Figure 5. SOCS5 interacts with a PI3K complex. (A–C) 293T cells were transiently transfected with constructs expressing Flag-tagged SOCS5, SOCS5
mutants or vector alone, lysed and SOCS5-containing complexes immunoprecipitated (IP) using anti-Flag antibodies. (A) Protein complexes were
analyzed by tryptic digest and mass spectrometry. Mean ± S.D. of summed peptide intensities from three replicates. The PI3K components, and SOCS5
and SOCS box components, were specifically enriched relative to immunoprecipitates from cells transfected with vector alone. (B,C) SOCS5-containing
protein complexes were analyzed by immunoblotting with the indicated antibodies. Lysates were probed with antibodies to Erk1/2 to show equal
protein input (lower panels). PV indicates pre-treatment of cells with pervanadate to inhibit phosphatase activity. mSH2: SOCS5-R406K; mSB: SOCS5-
L484P, C488F; DNT: residues 350–536. (D) A549 cells were pre-treated with the proteasomal inhibitor MG132 (6 h) and pervandate (20 min) prior to lysis.
Proteins were immunoprecipitated with either isotype control antibodies (Con) or SOCS5-specific antibodies (S5) and analyzed by immunoblotting with
the indicated antibodies.
DOI: 10.7554/eLife.20444.011
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Consistent with reduced PI3K p110a, SOCS5 also suppressed AKT phosphorylation in both healthy
and COPD hAECs (Figure 6F and Figure 6—figure supplements 1D and 2). Viral HA levels were
also significantly reduced (Figure 6F and Figure 6—figure supplements 1D and 2).
The changes in HA levels (within 2 h; Figure 6E and Figure 6—figure supplements 1C, 2 and
3) are occurring prior to viral replication, suggesting that SOCS5 impacts on very early events in the
viral life cycle. To explore this further, the experiment was repeated in the presence of PI3K (Wort-
mannin) and EGFR (Erlotinib) inhibitors. Both inhibitors normalized the Socs5-si difference (Fig-
ure 6—figure supplement 3), suggesting that the increase in viral HA protein at this early timepoint
derives from EGFR-mediated PI3K activity.
EGF receptor kinase activity mediates the enhanced susceptibility to
influenza infection in the absence of Socs5
We then investigated whether increases in EGFR or PI3K signaling caused the increased susceptibil-
ity to influenza infection in the absence of Socs5. Wild-type and Socs5 /  mice were treated with
either vehicle control (captisol), PI3K inhibitor (BKM-120) or EGFR inhibitor (Erlotinib) followed by
infection with H1N1 PR8 virus. Socs5 /  mice again exhibited elevated levels of virus in the lungs at
24 h post-inoculation, compared to controls. Treatment with the PI3K inhibitor significantly reduced
the amount of virus in both wild-type and Socs5 /  mice, with levels in Socs5 /  mice remaining
higher than that of wild-type mice. In contrast, treatment with the EGFR inhibitor Erlotinib selectively
reduced levels of virus in Socs5 /  mice, to the extent that they dropped below levels in wild-type
mice (Figure 7A).
Remarkably, the key observations were reproduced in both primary mouse and human epithelial
cell cultures following infection with H1N1 virus. PI3K inhibition (BKM-120 or Wortmannin) reduced
viral titres in primary mouse and human epithelial cells, with SOCS5-deficient cells retaining a signifi-
cantly higher level of infection compared to wild-type cells (Figures 7B and C). In contrast, inhibition
of EGFR activity (using either AG1478 or Erlotinib) reduced and normalized viral titres in wild-type
and Socs5 /  cells (Figures 7B and C).
Several key conclusions can be drawn from the inhibitor studies. Firstly, consistent with published
data, PI3K signaling is important for viral fitness. Secondly, despite the validity of PI3K as a potential
SOCS5 target, the increased susceptibility of Socs5 /  mice to influenza is due to altered EGFR sig-
naling. In this context the requirement for EGFR kinase activity predominates over EGFR-mediated
PI3K activity.
In summary, these data encapsulate several important findings. SOCS5 expression is upregulated
in response to influenza A virus infection in hAECs, suggesting that it has an important role in modu-
lating innate host defense. SOCS5 levels are reduced in hAECs from COPD patients and a highly
pathogenic avian virus (H5N1) actively reduced SOCS5 expression, thus linking SOCS5 to influenza
pathogenesis. Finally, we have shown in vivo and in primary human cells, that SOCS5 acts to
Table 2. Proteomic analysis of SOCS5 immunoprecipitates.
Summed peptide intensity #unique peptides
Accession number Protein names Gene names SOCS5* Vector SOCS5 Vector
P27986 PI3K p85 b PIK3R2 5.63E + 07 2.31E + 07 6.18E + 07 0 0 0 6 2 7 0 0 0
O00459 PI3K p85 a PIK3R1 5.57E + 07 2.60E + 07 7.02E + 07 0 0 0 7 2 6 0 0 0
P42338 PI3K p110 b PIK3CB 8.07E + 06 1.00E + 00 1.18E + 07 0 0 0 3 0 4 0 0 0
O54928 SOCS5 SOCS5 1.06E + 10 1.20E + 10 2.00E + 10 0 0 0 32 30 37 0 0 0
Q93034 Cullin-5 CUL5 1.08E + 10 7.01E + 09 1.31E + 10 0 0 0 54 46 51 0 0 0
Q9UBF6 RBX2 RNF7 7.23E + 08 4.36E + 08 1.10E + 09 0 0 0 4 3 4 0 0 0
Q15369 ElonginB TCEB1 1.41E + 09 9.89E + 08 8.69E + 08 0 0 4.78E + 06 5 5 5 0 0 1
Q15370 ElonginC TCEB2 2.92E + 09 1.40E + 09 3.30E + 09 0 0 0 10 7 8 0 0 0
* Data are shown from replicate samples.
DOI: 10.7554/eLife.20444.012
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Figure 6. Socs5 expression in primary human airway epithelial cells regulates EGFR-PI3K signaling and restrains influenza virus infection. Primary human
airway epithelial cells (hAECs) from healthy individuals, smokers with COPD and smokers without lung disease, were cultured as described and infected
with H3N2, H1N1 and H11N9 influenza virus strains (MOI 5). (A) 24 h post-infection Socs5 mRNA was measured by Q-PCR and is shown as the fold-
change from a media only control. Mean ± S.E.M.; n = 3. (B) Data for healthy controls shown in (A) is plotted against the expression of Socs5 mRNA
following infection with H5N1 (MOI 0.005). *p<0.05 Infection vs Media, +p<0.05 healthy vs COPD and H5N1 vs other subtypes/strains; Mean ± S.E.M.;
n = 3. (C–F) hAECs from healthy individuals and COPD patients were cultured and SOCS5 depleted using siRNA (C,E). Alternatively, SOCS5 expression
was increased in hAECs by transfection with SOCS5 cDNA (SOCS5 vector) (D,F) prior to infection with H1N1 (MOI 5). Cells were lysed at 24 h (C,D) or
2 h (E,F) post-infection and analyzed by immunoblotting with the indicated antibodies.
DOI: 10.7554/eLife.20444.013
The following figure supplements are available for figure 6:
Figure supplement 1. Socs5 expression in human primary airway epithelial cells regulates EGFR-PI3K signalling and restrains influenza infection.
DOI: 10.7554/eLife.20444.014
Figure supplement 2. Socs5 expression in human primary airway epithelial cells regulates EGFR-PI3K signalling and restrains influenza infection.
DOI: 10.7554/eLife.20444.015
Figure supplement 3. Socs5 expression in human primary airway epithelial cells regulates early events in influenza infection.
DOI: 10.7554/eLife.20444.016
Figure 6 continued on next page
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negatively regulate EGFR and PI3K signaling and while both are important positive mediators of
influenza virus infection, it is SOCS5 restriction of EGFR activity, which limits viral infection in lung
epithelium.
Discussion
Our data position SOCS5 as a pivotal regulator of influenza, a major global disease. Mortality related
to infection with highly pathogenic influenza strains is associated with the production of high levels
of inflammatory cytokines in the airways (in particular IL-6): the ‘cytokine storm’ (de Jong et al.,
2006). COPD is a progressive inflammatory disease of the airways that results from smoke exposure
(cigarette smoking and biomass smoke) and individuals suffering from COPD are at risk of severe
complications following infection with influenza and other respiratory viruses. We suggest that
SOCS5 acts as a central switch point, with changes in SOCS5 levels and/or activity impacting disease
outcome in individuals such as those with COPD, who exhibit increased susceptibility to influenza.
The Socs5 /  mice present a novel model of exacerbated human influenza, displaying increased
viral load, exaggerated cytokine production in the early phase of the infection and increased neutro-
phil trafficking into the airways (Figures 1 and 2). Although total depletion of neutrophils results in
worsened disease (Tate et al., 2011), their role is more complex. Neutrophils are strongly associated
with the inflammatory pathology observed in severe infections (Brandes et al., 2013;
Narasaraju et al., 2011; Perrone et al., 2008), and the process of NETosis has recently been shown
to induce inflammatory responses (McIlroy et al., 2014). Our results suggest that in Socs5 /  mice,
amplification of the inflammatory cascade occurs as the neutrophils die via NETosis, releasing pro-
inflammatory molecules such as HMBG1 and 2.
Influenza virus-induced EGFR, PI3K and AKT activity have each separately been shown to increase
viral entry and replication (Ehrhardt and Ludwig, 2009; Eierhoff et al., 2010; Hsu et al., 2015).
Here we link all three to the susceptibility and pathology associated with COPD patients and identify
SOCS5 as a key negative regulator of these pathways. While the individual differences observed in
AECs may appear modest, the defects in EGFR, PI3K and AKT need to be considered in combina-
tion and importantly, in the context of the entire lung. If these small differences occur across a large
part of the whole airways in COPD, then the airways will become more susceptible to influenza, as
will the patient. There is a fine balance between resistance and susceptibility to infection and these
changes could alter the balance towards infection, especially when combined with other immune
defects in COPD. Another example is the modest difference seen in IFN signaling in SOCS1-defi-
cient cells (Brysha et al., 2001; Wormald et al., 2006). While these differences appear small, the
consequences in vivo are devastating, SOCS1-deficient mice die of an IFN-driven inflammatory dis-
ease shortly after birth (Alexander et al., 1999) and similarly Socs1 /  Ifng /  mice die rapidly when
injected with IFNg (Brysha et al., 2001).
Influenza virus binding to sialic acids on the epithelial cell surface, results in clustering of lipid rafts
and crosslinking of surface receptors such as c-Met, PDGF and EGFR (Eierhoff et al., 2010). The
Class I PI3Ks consist of a heterodimer between a regulatory (p85) and a catalytic (p110) subunit of
which there are multiple variants (Cantley, 2002). Phosphorylated EGFR recruits p85 PI3K to the
receptor and activation of PI3K results in phosphorylation of phospholipids at the cell membrane,
facilitating endocytosis of the virus, presumably through reorganisation of the actin cytoskeleton
(Ehrhardt et al., 2006). In addition to this important role for PI3K signaling at the early stages of
infection, at later stages direct binding of the viral NS1 protein to PI3K enhances its stability and
activation, reducing cell death and maintaining a replicative niche for the virus (Hale et al., 2006).
EGFR signaling can also suppress the host anti-viral response, inhibiting RIG-I-driven type I interferon
production by an as yet, unknown mechanism (Ueki et al., 2013).
Figure 6 continued
Figure supplement 4. PI3K p110a is not targeted by SOCS5 for proteasomal degradation.
DOI: 10.7554/eLife.20444.017
Figure supplement 5. SOCS5 does not ubiquitinate PI3K p110a in vitro.
DOI: 10.7554/eLife.20444.018
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Figure 7. SOCS5 protects against influenza virus infection by suppressing virus-induced EGFR activity. (A) Mice
were infected i.n. with 35 pfu influenza virus H1N1 PR8 and viral titres determined in lung homogenates 24 h post-
PR8 infection, by plaque assay. Mice were treated with vehicle (captisol), PI3K inhibitor (BKM-120) or EGFR
inhibitor (Erlotinib) 4 h post-PR8 inoculation. (B) Primary mouse airway epithelial cells (mAEC) from wild-type and
Socs5 /  mice were purified and cultured in vitro for 7 days prior to infection with influenza virus H1N1 PR8 (MOI
1) and then incubated in the presence of trypsin for 24 h. PI3K (BKM-120) and EGFR inhibitors (AG1478) were
included in the culture media during and post-infection. Culture supernatants were analyzed for infectious virus by
Figure 7 continued on next page
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Although PI3K is often activated downstream of EGFR, our data also suggest that PI3K signaling
might be targeted by SOCS5 independently of the EGFR. Firstly, PI3K p110a levels were elevated in
the lungs of uninfected mice with no apparent corresponding increase in EGFR levels (Figure 4A).
Secondly, we captured a specific SOCS5/PI3K p85/p110 complex in 293T cells, in the absence of an
EGFR interaction (Figure 5A,B and Table 2). Although the PI3K p110a catalytic subunit was consti-
tutively elevated in Socs5 /  mouse lungs, expression of the p85 regulatory PI3K subunit appeared
to vary with infection (Figure 4A,B). A change in p110:p85 ratio in uninfected cells may prime for
enhanced PI3K catalytic activity (Ueki et al., 2002) following receptor tyrosine kinase activity or
direct activation by the influenza virus NS1 protein. This is further supported by the increased phos-
phorylation of the PI3K downstream substrate AKT in the lungs of Socs5-deficient mice during infec-
tion (Figures 4 and 6E).
Reduced SOCS5 expression in primary human epithelial cells also resulted in increased viral HA
protein within 2 h of infection, indicating that early events in the viral life cycle such as viral entry and
trafficking are enhanced. This appears to result from EGFR-driven PI3K activity, as inhibition of either
kinase ablated the SOCS5-dependent effects on HA levels (Figure 6—figure supplement 3). Activa-
tion of the viral detection pathways results in the cleavage and shedding of EGFR ligands such as
TGFa (Ito et al., 2015). If this were the case, EGFR activity may be enhanced in the absence of
SOCS5. Ligand-independent EGFR clustering is thought to preferentially result in autophosphoryla-
tion of the PI3K docking site (Tyr 992), but not that of other more distal sites (Huang et al., 2016).
We speculate that SOCS5 may inhibit virus-induced receptor clustering and autophosphorylation
and when SOCS5 is reduced, selective activation of the PI3K sites. Coupled with increased PI3K
p110 levels, this would give a net increase in PI3K activity at the membrane, resulting in increased
receptor endocytosis (enhanced entry).
Interestingly and somewhat surprisingly, the increase in viral titres observed in Socs5 /  mice at
24 h post-inoculation did not resolve with the inhibition of PI3K activity, despite the importance of
PI3K activity in this system and the evidence that SOCS5 can independently target PI3K (as dis-
cussed above). This suggests that in vivo, SOCS5 regulates PI3K-independent EGFR effects that are
required for restraint of the infection. There are many consequences of EGFR signaling, not least of
which is a Ras/MAPK-driven transcriptional response, which may explain the difference between the
in vivo results and the short-term infections in vitro in primary human cells.
The SOCS proteins are known to function as adaptors for E3 ubiquitin ligases. If SOCS5 regulated
phosphorylated EGFR or PI3K p110a by ubiquitination and proteasomal degradation, pEGFR/PI3K
levels should increase in the presence of a proteasomal inhibitor such as MG132 and the differences
observed with reduced or increased SOCS5 expression should be equalized. However, incubation
with MG132 did not change the levels of either target (Figure 6—figure supplement 4). Similarly,
the differences consistently observed with altered SOCS5 levels, were retained in the presence of
MG132 (Figure 6—figure supplement 4). Additionally, we were unable to demonstrate SOCS5-
mediated ubiquitination of PI3K p110a in an in vitro assay using recombinant proteins (Figure 6—
figure supplement 5). Collectively, this suggests that SOCS5 does not regulate either pEGFR or
PI3K through proteasomal degradation.
While proteasomal degradation would have been a reasonable explanation for the elevated
pEGFR and PI3K p110a levels in SOCS5-deficient lungs and cells, these results suggest that SOCS5
has alternate ways to modulate protein function and that its regulation of EGFR signaling is more
complex than earlier suppositions (Nicholson et al., 2005). SOCS1, SOCS3 and cytokine-inducible
SH2-containing (CIS) protein can interact with and inhibit the enzymatic activity of the JAK kinases
(Delconte et al., 2016; Linossi et al., 2013a). SOCS5 belongs to the sub-group of SOCS proteins
Figure 7 continued
plaque assay. (C) Primary human airway epithelial cells (hAECs) from healthy individuals were cultured as described
and infected with H1N1 strain (A/Auckland/1/2009; MOI 5). PI3K inhibitor (Wortmannin) and EGFR inhibitor
(Erlotinib) were added 3 h prior to virus inoculation. Culture supernatants were analyzed for infectious virus by
plaque assay 24 h post-infection. *p<0.05, **<0.005. (A–C; Mean ± S.E.M of indicated n). p values were
determined by (A,B) unpaired student’s t-test or (C) a Mann-Whitney U test.
DOI: 10.7554/eLife.20444.019
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with an extended N-terminal region (369 residues). It is likely that the N-terminal region acts as a
scaffold to regulate multiple proteins, in addition to its activity as an E3 ligase.
Whilst we don’t fully understand the mechanism, SOCS5 may inhibit the ability of EGFR to sup-
press RIG-I-IFN I production (Ueki et al., 2013), possibly through scaffolding larger complexes or
targeting an unknown substrate for ubiquitination. Alternatively, SOCS5 may effect a switch in EGFR
signaling the result of which is greater viral dependence on EGFR. This is apparent in the presence
of the PI3K inhibitor, where even larger differences are observed between SOCS5 wild-type and
depleted cells (Figure 7), and where the levels of virus in Socs5 /  cells drop below that of wild-
type cells in the presence of EGFR inhibitor (Figure 7A).
Although overexpression of SOCS5 in mammalian cells has been shown to downregulate EGF sig-
naling (Nicholson et al., 2005), Socs5 /  mice have no gross EGF-related phenotype
(Brender et al., 2004). Further, we have cultured Socs5 /  embryonic fibroblasts and found no dif-
ferences in EGF-induced signaling (data not shown). Thus there is a unique role for SOCS5 in regu-
lating viral activation of the EGFR in lung epithelial cells and this study confirms an important role for
endogenous EGFR activity in facilitating viral infections.
Identifying SOCS5 as a protective regulator of influenza infection and the subsequent hyper-
inflammatory response in airway epithelium, offers the potential to target either SOCS5 itself
(enhancing SOCS5 expression or using mimetics) or SOCS5 interacting proteins such as PI3K, to
reduce the damaging inflammation that is characteristic of severe influenza and chronic respiratory
diseases. Similarly, this study also raises the possibility that short-term use of EGFR inhibitors in
severe influenza may be beneficial, particularly when coupled with direct delivery to the lung; facili-
tating rapid action, whilst reducing systemic toxicity.
We have shown SOCS5 to be a critical regulator of the intracellular pathways that control influ-
enza virus infection. Mice lacking SOCS5 have higher viral loads and exhibit a neutrophilic inflamma-
tory response associated with increased morbidity. Importantly, restoring SOCS5 expression in
bronchial epithelial cells from COPD patients reduced viral entry, suggesting that targeting SOCS5
and/or its interacting partners may be valid intervention strategies to alleviate the severe pathology
associated with influenza virus infection in COPD patients, immunocompromised individuals or infec-
tion with highly pathogenic influenza strains. Future studies will attempt to understand why SOCS5
levels are reduced in epithelial cells from COPD patients.
Materials and methods
Influenza viruses
Human influenza A/Puerto Rico/8/1934 (H1N1; PR8), A/Auckland/1/2009 (H1N1) A/Wellington/43/
2006 (H3N2) and A/Vietnam/1203/04 (H5N1) strains and the avian influenza A/sharp-tailed sand-
piper/Australia/6/2004 (H11N9) (Hurt et al., 2006) strain were obtained from the WHO Collaborat-
ing Centre for Reference and Research on Influenza (Parkville, Victoria, Australia). All work with
H5N1 was performed in the Level 4 Containment Facility at the Commonwealth Scientific and Indus-
trial Research Organization (CSIRO), Australian Animal Health laboratory, Geelong, Victoria, Aus-
tralia. Viral titres were determined by plaque assay on monolayers of Madin Derby canine kidney
(MDCK; RRID:CVCL_0422) cells (Huprikar and Rabinowitz, 1980).
Mice
SOCS5-deficient mice (Socs5 / ) have been described previously (Brender et al., 2004) and were
backcrossed for 10 generations onto a BALB/c background. Socs4 /  and Sirpa /  Balb/c mice have
been described previously (Kedzierski et al., 2014; Legrand et al., 2011). All mice were bred at the
Walter and Eliza Hall Institute animal facility. Animal experiments followed the NHMRC Code of
Practice for the Care and Use of Animals for Scientific Purposes guidelines and were approved by
the Walter and Eliza Hall Institute’s Animal Ethics Committee.
Virus infection and tissue collection
Mice were lightly anaesthetized by inhalation of methoxyflurane and infected intranasally (i.n.) with
25–50 plaque-forming units (pfu) of PR8 influenza virus. Kinase inhibitors or vehicle were adminis-
tered 3 h prior to infection with PR8 influenza virus. The EGFR inhibitor Erlotinib (MedKoo
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Biosciences) was administered by oral gavage (20 mg/kg in 6% Captisol), the PI3K inhibitor BKM-120
(Active Biochem) by I.P. injection (50 mg/kg in 12% Captisol). Control mice received 12% Captisol
(Ligand Pharmaceuticals) by I.P. injection.
Weight was monitored daily as early as from day one post-infection. Mice were sacrificed at vari-
ous time points and bronchoalveolar lavage (BAL) samples and entire lungs collected for analysis.
Lungs were mechanically homogenised using a Polytron System PT 1200 (Kinematica), centrifuged at
836 g for 10 min and the supernatant harvested for detection of infectious virus by plaque assay or
for cytokine analysis. Alternatively, lungs were collected in TRIZOL (Invitrogen) and homogenised for
Q-PCR analysis or snap-frozen in liquid nitrogen prior to protein analysis.
Immunophenotypic staining
Cells recovered from BAL samples were stained with antibodies to CD4-PE, B220-APC, CD8-PerCP,
CD11b-FITC, CD11c-APC, Ly6C-PerCP (BD Biosciences or BioLegend) and analyzed by flow cytome-
try on a FACS Canto (BD Biosciences), using FlowJo software (Tree Star). Different combinations of
antibodies were used as indicated in the text.
Bone marrow chimeras
Bone marrow chimeras were established as previously described (Kedzierski et al., 2014). Briefly,
irradiated recipient mice (BALB/c Thy1.1) were reconstituted by I.V. injection with 3  106 T cell-
depleted bone marrow cells from donor mice (Thy1.2 Socs5 / or BALB/c). Following injection, the
mice were allowed to reconstitute for at least eight weeks prior to use, blood samples were col-
lected (by submandibular bleeding), and reconstitution assessed by FACS analysis of Thy 1.2/Thy 1.1
T cells. On average, wild-type mice showed >80% reconstitution with Socs5 /  bone marrow, while
Socs5 /  mice showed >70% reconstitution with wild-type bone marrow.
Immunohistochemistry
BALB/c and Socs5 /  control mice were inoculated with 50 pfu influenza virus PR8 and lungs har-
vested at day three post-infection. Uninfected lungs were collected as controls. Sections were incu-
bated with SOCS5 polyclonal rabbit antibody (Abcam), followed by biotinylated secondary antibody,
and antibody binding visualized using ABC reagent (Fuzhou Maixin Biotechnology) as per the manu-
facturer’s instructions. Slides were counterstained with hematoxylin. See also Supplementary
information.
Cytokine analysis
Cytokine levels in BAL were analyzed using the BioPlex Pro Assay (BioRad). IFNa and b were
detected in lung homogenates by sandwich ELISA using the following mouse monoclonal capture
antibodies, IFNa (clone F18; Thermo Scientific), IFNb (clone 7F-D3; Abcam), together with biotiny-
lated detection antibodies (PBL Interferon Source). IFNg2 was detected by ELISA (R and D Systems).
Preparation of primary mouse airway epithelial cells (mAEC)
Mouse AEC cultures were prepared as described (Thomas et al., 2014), with minor modifications.
Briefly, lungs were digested in 1.5 mg/mL Pronase (Roche) and 0.1 mg/ml DNase I (Sigma-Aldrich)
for 60 min at 37˚C in 5% CO2. Single cell suspensions were incubated with purified rat anti-mouse
CD45 antibody (BD Biosciences) and epithelial cells negatively enriched using BioMag goat anti-rat
Ig-coupled magnetic beads (Qiagen). Flow cytometry was used to confirm cell purity, which was
approximately 95% with mouse anti-EpCAM antibodies (BioLegend) and cultures were on average
20% positive for podoplanin (AEC type I) and 70% for CD74 (AEC type II).
Infection of mAEC
Monolayers of mAEC at approximately 80% confluency, were incubated with the influenza strain PR8
(MOI as indicated) in serum free media for 1 h, washed and then placed in media supplemented
with 2% FCS. To examine virus infection, cells were fixed with 80% acetone at 8 h post-infection and
stained with anti-nuclear viral protein antibodies, as described (Tate et al., 2010). The percentage
of infected cells was determined in a minimum of four random fields with at least 200 cells counted
per sample. To examine virus replication, monolayers of mAEC were incubated with PR8 (MOI 1) in
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serum free media for 1 h and then incubated in media supplemented with 2% FCS and 4 mg/mL tryp-
sin. Levels of infectious virus in cell supernatants were determined by plaque assay on MDCK cells.
Real-time quantitative PCR (Q-PCR)
Real-time Q-PCR was performed essentially as described (Lee et al., 2009). Additional primers
sequences are as follows: hIFNl Forward (F): ACAGCTTCAGGCCACAGCAGAGC; Reverse (R): ccag-
gagtctccttgctctggg, hSOCS5 F: GCCACAGAAATCCCTCAAATTG; R:ggagcatgtcgagagtaggaatct,
hRIG-I F: GCCCTCATTATCAGTGAGCA; R: ATCTCATCGAATCCTGCTGC. Relative expression was
determined by normalizing the amount of each gene to the housekeeping gene mouse 18s rRNA
using the following primer sequences: F: ACGGACCAGAGCGAAAGCAT and R: CGGCATCGTTTA
TGGTCGGA or to human hypoxanthine phosphoribosyltransferase (HPRT).
Antibodies and reagents
The mouse monoclonal antibody to SOCS5 was generated in-house and recognises an epitope in
the SOCS5 N-terminal region. Antibodies to phospho-EGFR (Tyr 1068), EGFR, PI3K p85, PI3K
p110a, RIG-I, phospho-MAPK (Thr202/204), MAPK, phospho-AKT1 (Ser473), AKT, phospho-STAT3
and STAT3 were obtained from Cell Signaling Technology. Anti-human SOCS5, anti-GAPDH and
anti-avian Influenza A hemagglutinin antibodies were obtained from Abcam.
Immunoprecipitation and immunoblotting
Whole lungs were dounce homogenized in KALB lysis buffer (Linossi et al., 2013b). Protein concen-
trations were determined by the BCA method (Pierce). A549 cells (RRID:CVCL_0023) were treated
with 10 mM MG132 (6 h) and pervanadate solution (H2O2/25 mM Na3VO4) (20 min) prior to cell lysis
in 1% NP-40 buffer (1% v/v NP-40, 50 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM NaF, 1
mM Na3VO4). SOCS5 was immunoprecipitated using the in-house anti-SOCS5 antibody conjugated
to Sepharose. Alternatively, 293 T cells (RRID:CVCL_0063) were transiently transfected with vector
alone or cDNA expressing Flag-tagged mouse SOCS5, using FuGene6 (Promega). 48 h post-trans-
fection, cells were pre-treated with pervanadate solution for 30 min and lysed in 1% NP-40 buffer.
Flag-SOCS5 was immunoprecipitated using M2-beads (Sigma) and proteins eluted with 0.5% sodium
dodecyl sulfate (SDS) and 5 mM dithiothreitol (DTT), prior to tryptic digest and mass spectrometry.
Endogenous SOCS5 was immunoprecipitated using 5 mg in-house antibody and protein-A Sephar-
ose. Wild-type and mutant SOCS5 expression vectors, immunoprecipitation, gel electrophoresis and
immunoblotting have been described previously (Linossi et al., 2013b). Cell lines were tested as
mycoplasma free.
Trypsin digestion
Equal amounts of lung lysates (~200 mg) or eluates from SOCS5 immunoprecipitates were subjected
to tryptic digest using the FASP protein digestion kit (Protein Discovery) (Wiśniewski et al., 2009),
Table 3. Subject characteristics.
Healthy COPD Smoker P – value
Number 5 5 5 NA
Sex (% Female) 60% 60% 40% p=0.6
Mean Age (S.D.) 61 (16.29) 68 (12.35) 64.33 (12.82) p=0.07
Mean FEV1 (S.D.)
* 98% (8.61) 43% (10.63) 97.5% (10.30) p<0.001
Cigarette (Packs/year; S.D.) 0 43 (10.66) 23 (11.54) p<0.001
Years abstinent (S.D.) 0 12.35 (5.28) 0 NA
ICS (percent treated) 0 Seretide/Tiotropium/Salbutamol (60%)
Tiotropium (40%)
0 NA
* FEV1 refers to the forced expiratory volume in 1s expressed as a percentage of the predicated value.
The statistical analysis used for this table is ANOVA for multiple groups.
NA = Not applicable.
DOI: 10.7554/eLife.20444.020
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with the following modifications. Protein material was reduced with TCEP (5 mM final) and digested
overnight with 2 mg sequence-grade modified trypsin Gold (Promega) in 50 mM NH4HCO3 at 37˚C.
Peptides were eluted with 50 mM NH4HCO3 in two 40 mL sequential washes and acidified in 1% for-
mic acid (final). Mass spectrometric analysis was performed as described in Appendix 1.
Primary human cell culture, viral infection and siRNA depletion
Primary human airway epithelial cells (hAECs) were obtained by endobronchial brushing during
fibre-optic bronchoscopy from healthy individuals, individuals who smoked but had no history of
lung disease, or individuals who smoked and had chronic obstructive pulmonary disease (COPD).
Healthy subjects had no history of smoking or lung disease and had normal lung function. See
Table 3 for patient details. All subjects gave written informed consent and all procedures were per-
formed according to approval from the University of Newcastle Human Ethics Committee. hAEC
were cultured as described and used at passage two (Hsu et al., 2015). H1N1 (A/Auckland/1/2009),
H3N2, H11N9 and H5N1 were diluted in the appropriate serum free media and added to cells at an
MOI of 5 (H3N2, H1N1, and H11N9) and 0.005 (H5N1). After 1 h the virus was removed and
replaced with serum-free media. Cells were lysed 24 h post-infection and analyzed by Q-PCR or
immunoblotting. Socs5 was depleted using Silencer Select pre-designed siRNAs (Life Technologies),
which were reverse transfected into hAECs using siPORT NeoFX transfection agent (Life Technolo-
gies), 24 h prior to infection. Wortmannin (100 nM; Sigma-Aldrich) or Erlotinib (100 nM; Selleckchem)
was added to hAECs 24 h before infection or 1 h after virus inoculation.
Statistical analysis
Statistical analysis was performed using an unpaired t-test with a 95% confidence level.
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Lungs were fixed in 4% paraformaldehyde and embedded in paraffin. For
immunohistochemistry, slides were baked at 68˚C for 60 min, deparafinized twice in xylene
(10 min), followed by rehydration in graded dilutions of ethanol in water (100%, 100%, 95%,
90%, 80%, 70%; 5 min for the first two dilutions then 3 min for subsequent dilutions), and
washed in PBS. Antigen retrieval was performed by heating the slides in citrate buffer (pH
6.0) for 20 min at 92˚C. Cooled slides were washed twice in PBS and incubated in 3% H2O2
for 10 min at room temperature (RT) followed by PBS washes. Blocking was performed in 2%
bovine serum albumin (BSA) for 20 min followed by overnight staining at 4˚C with SOCS5
polyclonal rabbit antibody (Abcam). Slides were washed three times in PBS and incubated
with biotinylated secondary antibody and ABC reagent as per the manufacturer’s
instructions. Slides were counterstained with hematoxylin and mounted in Permount
Mounting Medium (Fisher Scientific).
Quantification of cell-free dsDNA
Cell-free bronchoalveolar lavage samples were incubated with Proteinase K (Roche) 2.5 mg/mL
for 1 h at 37˚C on an orbital shaker. PicoGreen (Invitrogen) was used to measure the dsDNA
content of the protease-treated solution (Chen et al., 2007) according to manufacturer’s
instructions. dsDNA content was compared to a standard curve of lambda DNA (Invitrogen).
Mass spectrometry (MS) and data analysis
Acidified peptide mixtures were analyzed by nanoflow reversed-phase liquid chromatography
tandem mass spectrometry (LC-MS/MS) on a nanoAcquity system (Waters) coupled to a
Q-Exactive mass spectrometer equipped with a nanoelectrospray ion source for automated
MS/MS. (Thermo Fisher Scientific). Peptide mixtures were loaded on a 20 mm trap column
with 180 mm inner diameter (nanoAcquity UPLC 2 G-V/MTrap 5 mm Symmetry C18) at 1%
buffer B, and separated by reverse-phase chromatography using a 150 mm column with 75
mm inner diameter (nanoAcquity UPLC 1.7 mm BEH130 C18) on a 60 min linear gradient set
at a constant flow rate of 300 nL/min from 100% buffer A (0.1% formic acid, Milli-Q water) to
30% B (0.1% formic acid, acetonitrile). The Q-Exactive was operated in a data-dependent
mode, switching automatically between one full-scan and subsequent MS/MS scans of the
ten most abundant peaks. The instrument was controlled using Exactive series version 2.1
build 1502 and Xcalibur 3.0. Full-scans (m/z 350–1850) were acquired with a resolution of
70,000 at 200 m/z. The 10 most intense ions were sequentially isolated with a target value of
10000 ions and an isolation width of 2 m/z and fragmented using HCD with normalized
collision energy of 19.5 and stepped collision energy of 15%. Maximum ion accumulation
times were set to 50 ms for full MS scan and 200 ms for MS/MS. Underfill ratio was set to
5% and dynamic exclusion was enabled and set to 90 s.
Raw files consisting of high-resolution MS/MS spectra were processed with MaxQuant
(version 1.5.2.8) for feature detection and protein identification using the Andromeda search
engine (Cox et al., 2011). Extracted peak lists were searched against the UniProtKB/Swiss-
Prot Mus musculus and Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) databases and
a separate reverse decoy database to empirically assess the false discovery rate (FDR) using
strict trypsin specificity allowing up to three missed cleavages. The minimum required
peptide length was set to seven amino acids.
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Modifications: Carbamidomethylation of Cys was set as a fixed modification, while
N-acetylation of proteins, oxidation of Met, the addition of pyroglutamate (at N-termini Glu
and Gln), phosphorylation (Ser, Thr and Tyr), deamidation (Asn, Gln and Arg), were set as
variable modifications. Deamidation of arginines was used to identify citrullinated peptides,
resulting in a mass increase of 1 Da. The mass tolerance for precursor ions and fragment
ions were 20 ppm and 0.5 Da, respectively. The ‘match between runs’ option in MaxQuant
was used to transfer identifications made between runs on the basis of matching precursors
with high mass accuracy (Cox and Mann, 2008). PSM and protein identifications were
filtered using a target-decoy approach at a FDR of 1%. Protein identification was based on a
minimum of two unique peptides.
Quantitative proteomics analysis
Further analysis was performed using a custom pipeline developed in Pipeline Pilot (Biovia) and
R, which utilizes the MaxQuant output files allPeptides.txt, peptides.txt and evidence.txt. A
feature was defined as the combination of peptide sequence, charge and modification.
Features not found in at least half the number of replicates in each group were removed.
Proteins identified from hits to the reverse database and proteins with only one unique
peptide were also removed. To correct for injection volume variability, feature intensities
were normalized by converting to base two logarithms and then multiplying each value by
the ratio of maximum median intensity of all replicates over median replicate intensity.
Features assigned to the same protein differ in the range of intensity due to their chemico-
physical properties and charge state. To further correct for these differences, each intensity
value was multiplied by the ratio of the maximum of the median intensities of all features for
a protein over the median intensity of the feature. Missing values were imputed using a
random normal distribution of values using the mean of the real distribution of values minus
1.8 standard deviations, and a standard deviation of 0.5 times the standard deviation of the
distribution of the measured intensities (Cox et al., 2014). The probability of differential
expression between groups was calculated using the Wilcoxon Rank Sum test excluding any
non-unique sequences and any features with modifications other than oxidation and
carbamidomethylation. Probability values were corrected for multiple testing using
Benjamini–Hochberg method. Cut-off lines with the function y=  log10(0.05)+c/(x-x0)
(Keilhauer et al., 2015) were introduced to identify significantly enriched proteins. c was set
to 0.2 while x0 was set to 1 or 2, representing proteins with a 2-fold (log2 protein ratio of 1)
or 4-fold (log2 protein ratio of 2) change in protein expression, respectively. The Log2-
transformed summed peptide intensities (non-imputed) were visualised in a heat map
generated in one-matrix CIMminer, a program developed by the Genomics and
Bioinformatics Group (Laboratory of Molecular Pharmacology, Center for Cancer Research,
National Cancer Institute).
In vitro ubiquitination assays
GST-tagged SOCS5 (SH2 domain and SOCS box) in complex with the adapter proteins Elongin
B and C was expressed and purified from E. coli as previously described (Linossi et al.,
2013b). Recombinant PI3K (p110a/p85a; V1721) was purchased from Promega. Additional
components of the E3 ligase complex (Cullin 5, Rbx2, E2 and E1) were generated as
described (Kershaw et al., 2014). Full-length, Flag-tagged SOCS5 was expressed and
purified from HEK293T cells as previously described (Linossi et al., 2013b). Reactions were
carried out in 2 mM MgCl2, 2 mM ATP, 25 mM Tris-HCL, pH 7.4 and 1 mM DTT.
Ubiquitination reactions were initiated at 37˚C by the addition of the E1 enzyme and
terminated by the addition of 4x Laemlli reducing sample buffer. Samples were separated
by SDS page and transferred to nitrocellulose for immunoblot analysis of PI3K p110a.
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Bronchial epithelial cell line
The minimally immortalised bronchial epithelial cell line (BCi-NS1.1; Walters et al., 2013) was
cultured in BEBM complete media (Lonza) and was obtained from R.G. Crystal (Weill Cornell
Medical College, New York). It was tested as mycoplasma free.
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